Your browser doesn't support javascript.
loading
Fasting-sensitive SUMO-switch on Prox1 controls hepatic cholesterol metabolism.
Alfaro, Ana Jimena; Dittner, Claudia; Becker, Janina; Loft, Anne; Mhamane, Amit; Maida, Adriano; Georgiadi, Anastasia; Tsokanos, Foivos-Filippos; Klepac, Katarina; Molocea, Claudia-Eveline; El-Merahbi, Rabih; Motzler, Karsten; Geppert, Julia; Karikari, Rhoda Anane; Szendrödi, Julia; Feuchtinger, Annette; Hofmann, Susanna; Karaca, Samir; Urlaub, Henning; Berriel Diaz, Mauricio; Melchior, Frauke; Herzig, Stephan.
Affiliation
  • Alfaro AJ; Institute for Diabetes and Cancer, Helmholtz Munich, Neuherberg, Germany.
  • Dittner C; Joint Heidelberg-IDC Translational Diabetes Program, Inner Medicine 1, Heidelberg University Hospital, Heidelberg, Germany.
  • Becker J; German Center for Diabetes Research (DZD), and German Center for Cardiovascular Disease (DZHK), Neuherberg, Germany.
  • Loft A; Zentrum für Molekulare Biologie der Universität Heidelberg (ZMBH), Heidelberg University, DKFZ-ZMBH Alliance, Heidelberg, Germany.
  • Mhamane A; Zentrum für Molekulare Biologie der Universität Heidelberg (ZMBH), Heidelberg University, DKFZ-ZMBH Alliance, Heidelberg, Germany.
  • Maida A; Institute for Diabetes and Cancer, Helmholtz Munich, Neuherberg, Germany.
  • Georgiadi A; Joint Heidelberg-IDC Translational Diabetes Program, Inner Medicine 1, Heidelberg University Hospital, Heidelberg, Germany.
  • Tsokanos FF; German Center for Diabetes Research (DZD), and German Center for Cardiovascular Disease (DZHK), Neuherberg, Germany.
  • Klepac K; Center for Functional Genomics and Tissue Plasticity (ATLAS), SDU, Odense, Denmark.
  • Molocea CE; Institute for Diabetes and Cancer, Helmholtz Munich, Neuherberg, Germany.
  • El-Merahbi R; Joint Heidelberg-IDC Translational Diabetes Program, Inner Medicine 1, Heidelberg University Hospital, Heidelberg, Germany.
  • Motzler K; German Center for Diabetes Research (DZD), and German Center for Cardiovascular Disease (DZHK), Neuherberg, Germany.
  • Geppert J; Institute for Diabetes and Cancer, Helmholtz Munich, Neuherberg, Germany.
  • Karikari RA; Joint Heidelberg-IDC Translational Diabetes Program, Inner Medicine 1, Heidelberg University Hospital, Heidelberg, Germany.
  • Szendrödi J; German Center for Diabetes Research (DZD), and German Center for Cardiovascular Disease (DZHK), Neuherberg, Germany.
  • Feuchtinger A; Institute for Diabetes and Cancer, Helmholtz Munich, Neuherberg, Germany.
  • Hofmann S; Joint Heidelberg-IDC Translational Diabetes Program, Inner Medicine 1, Heidelberg University Hospital, Heidelberg, Germany.
  • Karaca S; German Center for Diabetes Research (DZD), and German Center for Cardiovascular Disease (DZHK), Neuherberg, Germany.
  • Urlaub H; Institute for Diabetes and Cancer, Helmholtz Munich, Neuherberg, Germany.
  • Berriel Diaz M; Joint Heidelberg-IDC Translational Diabetes Program, Inner Medicine 1, Heidelberg University Hospital, Heidelberg, Germany.
  • Melchior F; German Center for Diabetes Research (DZD), and German Center for Cardiovascular Disease (DZHK), Neuherberg, Germany.
  • Herzig S; Institute for Diabetes and Cancer, Helmholtz Munich, Neuherberg, Germany.
EMBO Rep ; 24(10): e55981, 2023 Oct 09.
Article in En | MEDLINE | ID: mdl-37560809

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Diagnostic_studies Language: En Journal: EMBO Rep Journal subject: BIOLOGIA MOLECULAR Year: 2023 Document type: Article Affiliation country: Alemania Country of publication: Reino Unido

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Diagnostic_studies Language: En Journal: EMBO Rep Journal subject: BIOLOGIA MOLECULAR Year: 2023 Document type: Article Affiliation country: Alemania Country of publication: Reino Unido